Reduction in the protein level of c-Jun and phosphorylation of Ser73-c-Jun in rat frontal cortex after repeated MK-801 treatment

Psychiatry Research

Volumn 167, Issue 1-2, 2009, Pages 80-87

  Ahn, Yong Min ^a   Seo, Myoung Suk ^b   Kim, Se Hyun ^a   Jeon, Won Je ^b   Kim, Yeni ^a   Kang, Ung Gu ^a   Juhnn, Yong Sung ^a   Kim, Yong Sik ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University Hospital   (South Korea)

Author keywords

JNK; MAPK; NMDA receptor antagonist; Psychosis; Psychotomimetic agent

Indexed keywords

DIZOCILPINE; PROTEIN C JUN; SERINE; TRANSCRIPTION FACTOR JUNB; TRANSCRIPTION FACTOR JUND;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFICACY; DRUG EXPOSURE; DRUG MECHANISM; FRONTAL CORTEX; LONG TERM CARE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN PHOSPHORYLATION; RAT; REPEATED DRUG DOSE; SINGLE DRUG DOSE;

ANIMALS; ANTIPSYCHOTIC AGENTS; APOPTOSIS; BEHAVIOR, ANIMAL; DIZOCILPINE MALEATE; DOWN-REGULATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FRONTAL LOBE; MALE; NEURONS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-JUN; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; SCHIZOPHRENIA; SIGNAL TRANSDUCTION;

EID: 64649104671     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psychres.2007.12.013     Document Type: Article

References (44)

1. Ahn Y.M., Kang U.G., Park J.B., and Kim Y.S. Effects of MK-801 and electroconvulsive shock on c-Fos expression in the rat hippocampus and frontal cortex. Progress in Neuro-psychopharmacology & Biological Psychiatry 26 (2002) 513-517
2. Ahn Y.M., Seo M.S., Kim S.H., Kim Y., Yoon S.C., Juhnn Y.S., and Kim Y.S. Increased phosphorylation of Ser473-Akt, Ser9-GSK-3beta and Ser133-CREB in the rat frontal cortex after MK-801 intraperitoneal injection. International Journal of Neuropsychopharmacology 5 (2005) 607-613
3. Ahn Y.M., Seo M.S., Kim S.H., Kim Y., Juhnn Y.S., and Kim Y.S. The effects of MK-801 on the phosphorylation of Ser338-c-Raf-MEK-ERK pathway in the rat frontal cortex. International Journal of Neuropsychopharmacology 9 (2006) 451-456
4. Andine P., Widermark N., Axelsson R., Nyberg G., Olofsson U., Martensson E., and Sandberg M. Characterization of MK-801-induced behavior as a putative rat model of psychosis. Journal of Pharmacology and Experimental Therapeutics 290 (1999) 1393-1408
5. Brecht S., Simler S., Vergnes M., Mielke K., Marescaux C., and Herdegen T. Repetitive electroconvulsive seizures induce activity of c-Jun N-terminal kinase and compartment-specific desensitization of c-Jun phosphorylation in the rat brain. Brain Research Molecular Brain Research 68 (1999) 101-108
6. Carey R.J., Dai H., Krost M., and Huston J.P. The NMDA receptor and cocaine: evidence that MK-801 can induce behavioral sensitization effects. Pharmacology, Biochemistry, and Behavior 51 (1995) 901-908
7. Carter K., Dickerson J., Schoepp D.D., Reilly M., Herring N., Williams J., Sallee F.R., Sharp J.W., and Sharp F.R. The mGlu2/3 receptor agonist LY379268 injected into cortex or thalamus decreases neuronal injury in retrosplenial cortex produced by NMDA receptor antagonist MK-801: possible implications for psychosis. Neuropharmacology 47 (2004) 1135-1145
8. Deng X., Jayanthi S., Ladenheim B., Krasnova I.N., and Cadet J.L. Mice with partial deficiency of c-Jun show attenuation of methamphetamine-induced neuronal apoptosis. Molecular Pharmacology 62 (2002) 993-1000
9. Eilers A., Whitfield J., Babij C., Rubin L.L., and Ham J. Role of the Jun kinase pathway in the regulation of c-Jun expression and apoptosis in sympathetic neurons. Journal of Neuroscience 18 (1998) 1713-1724
10. Gao X.M., Hashimoto T., and Tamminga C.A. Phencyclidine (PCP) and dizocilpine (MK801) exert time-dependent effects on the expression of immediate early genes in rat brain. Synapse 29 (1998) 14-28
11. Gass P., Herdegen T., Bravo R., and Kiessling M. Induction and suppression of immediate early genes in specific rat brain regions by the non-competitive N-methyl-d-aspartate receptor antagonist MK-801. Neuroscience 53 (1993) 749-758
12. Goldman-Rakic P.S. The physiological approach: functional architecture of working memory and disordered cognition in schizophrenia. Biological Psychiatry 46 (1999) 650-661
13. Hertzman M., Reba R.C., and Kotlyarove E.V. Single photon emission computerized tomography in phencyclidine and related drug abuse. American Journal of Psychiatry 147 (1990) 255-256
14. Jackson M.E., Homayoun H., and Moghaddam B. NMDA receptor hypofunction produces concomitant firing rate potentiation and burst activity reduction in the prefrontal cortex. Proceedings of the National Academy of Sciences of the United States of America 101 (2004) 8467-8472
15. Jentsch, J.D., Roth, R.H., 1999. The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 20, 201-225.
16. Jentsch J.D., Tran A., Le D., Youngren K.D., and Roth R.H. Subchronic phencyclidine administration reduces mesoprefrontal dopamine utilization and impairs prefrontal cortical-dependent cognition in the rat. Neuropsychopharmacology 17 (1997) 92-99
17. Kang U.G., Koo Y.J., Jeon W.J., Park D.B., Juhnn Y.S., Park J.B., and Kim Y.S. Activation of extracellular signal-regulated kinase signaling by chronic electroconvulsive shock in the rat frontal cortex. Psychiatry Research 145 (2006) 75-78
18. Keilhoff G., Bernstein H.G., Becker A., Grecksch G., and Wolf G. Increased neurogenesis in a rat ketamine model of schizophrenia. Biological Psychiatry 56 (2004) 317-322
19. Kitayama T., Yoneyama M., and Yoneda Y. Possible regulation by N-methyl-d-aspartate receptors of proliferative progenitor cells expressed in adult mouse hippocampal dentate gyrus. Journal of Neurochemistry 84 (2003) 767-780
20. Kontkanen O., Lakso M., Wong G., and Castren E. Chronic antipsychotic drug treatment induces long-lasting expression of fos and jun family genes and activator protein 1 complex in the rat prefrontal cortex. Neuropsychopharmacology 27 (2002) 152-162
21. Kyosseva S.V. Differential expression of mitogen-activated protein kinases and immediate early genes fos and jun in thalamus in schizophrenia. Progress in Neuro-psychopharmacology & Biological Psychiatry 28 (2004) 997-1006
22. Kyosseva S.V., Owens S.M., Elbein A.D., and Karson C.N. Differential and region-specific activation of mitogen-activated protein kinases following chronic administration of phencyclidine in rat brain. Neuropsychopharmacology 24 (2001) 267-277
23. Kyriakis J.M., Banerjee P., Nikolakaki E., Dai T., Rubie E.A., Ahmad M.F., Avruch J., and Woodget J.R. The stress-activated protein kinase subfamily of c-Jun kinases. Nature 369 (1994) 156-160
24. Le-Niculescu H., Bonfoco E., Kasuya Y., Claret F.X., Green D.R., and Karin M. Withdrawal of survival factors results in activation of the JNK pathway in neuronal cells leading to Fas ligand induction and cell death. Molecular Cell Biology 19 (1999) 751-763
25. Molinuevo J.L., Llado A., and Rami L. Memantine: targeting glutamate excitotoxicity in Alzheimer's disease and other dementias. American Journal of Alzheimer's Disease and Other Dementias 20 (2005) 77-85
26. Muller S., Berger M., Lehembre F., Seeler J.S., Haupt Y., and Dejean A. c-Jun and p53 activity is modulated by SUMO-1 modification. Journal of Biological Chemistry 275 (2000) 13321-13329
27. Musti A.M., Treier M., and Bohmann D. Reduced ubiquitin-dependent degradation of c-Jun after phosphorylation by MAP kinases. Science 275 (1997) 400-402
28. Olney J.W., and Farber N. NMDA antagonist as neurotherapeutic drugs, psychotogens, neurotoxins, and research tools for studying schizophrenia. Neuropsychopharmacology 13 (1995) 335-345
29. Paulson L., Martin P., Persson A., Nilsson C.L., Ljung E., Westman-Brinkmalm A., Eriksson P.S., Blennow K., and Davidsson P. Comparative genome and proteome analysis of cerebral cortex from MK-801-treated rats. Journal of Neuroscience Research 71 (2003) 526-533
30. Pulverer B.J., Kyriakis J.M., Avruch J., Nikolakaki E., and Woodgett J.R. Phosphorylation of c-jun mediated by MAP kinases. Nature 353 (1991) 670-674
31. Raivich G., and Behrens A. Role of the AP-1 transcription factor c-Jun in developing, adult and injured brain. Progress in Neurobiology 78 (2006) 347-363
32. Seo M.S., Kim S.H., Ahn Y.M., Kim Y., Jeon W.J., Yoon S.C., Roh M.S., Juhnn Y.S., and Kim Y.S. The effects of repeated administrations of MK-801 on ERK and GSK-3beta signalling pathways in the rat frontal cortex. International Journal of Neuropsychopharmacology 10 (2007) 359-368
33. Sharp F.R., Jasper P., Hall J., Noble L., and Sagar S.M. MK-801 and ketamine induce heat shock protein HSP72 in injured neurons in posterior cingulate and retrosplenial cortex. Annals of Neurology 30 (1991) 801-809
34. Stephan K.E., Baldeweg T., and Friston K.J. Synaptic plasticity and dysconnection in schizophrenia. Biological Psychiatry 59 (2006) 929-939
35. Takahata R., and Moghaddam B. Activation of glutamate neurotransmission in the prefrontal cortex sustains the motoric and dopaminergic effects of phencyclidine. Neuropsychopharmacology 28 (2003) 1117-1124
36. Thomas D.M., and Kuhn D.M. MK-801 and dextromethorphan block microglial activation and protect against methamphetamine-induced neurotoxicity. Brain Research 1050 (2005) 190-198
37. Todorova V.K., Elbein A.D., and Kyosseva S.V. Increased expression of c-Jun transcription factor in cerebellar vermis of patients with schizophrenia. Neuropsychopharmacology 28 (2003) 1506-1514
38. Tomitaka M., Tomitaka S., Rajdev S., and Sharp F.R. Fluoxetine prevents PCP- and MK801-induced HSP70 expression in injured limbic cortical neurons of rats. Biological Psychiatry 47 (2000) 836-841
39. Vaisanen J., Ihalainen J., Tanila H., and Castren E. Effects of NMDA-receptor antagonist treatment on c-fos expression in rat brain areas implicated in schizophrenia. Cellular and Molecular Neurobiology 24 (2004) 769-780
40. Waetzig V., and Herdegen T. The concerted signaling of ERK1/2 and JNKs is essential for PC12 cell neuritogenesis and converges at the level of target proteins. Molecular and Cellular Neurosciences 24 (2003) 238-249
41. Watson A., Eilers A., Lallemand D., Kyriakis J., Rubin L.L., and Ham J. Phosphorylation of c-Jun is necessary for apoptosis induced by survival signal withdrawal in cerebellar granule neurons. Journal of Neuroscience 18 (1998) 751-762
42. Wedzony K., Golembiowska K., and Klimek V. MK-801-induced symptoms of sensitization. The lack of correlation with the extracellular concentration of dopamine in the rat prefrontal cortex. Brain Research 625 (1993) 333-336
43. Xia Z., Dickens M., Raingeaud J., Davis R.J., and Greenburg M.E. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270 (1995) 1326-1331
44. Yang P.B., Swann A.C., and Dafny N. Valproate prevents the induction and the expression of MK-801 sensitization. Brain Research 954 (2002) 151-159